Stockholders’ Equity (Details) - USD ($)						1 Months Ended				12 Months Ended
	Apr. 14, 2021	Feb. 09, 2021	Aug. 03, 2020	Apr. 18, 2020	Apr. 15, 2020	Jan. 18, 2021	Apr. 28, 2020	Apr. 17, 2020	Apr. 15, 2020	Dec. 31, 2021	Dec. 31, 2020	Mar. 10, 2021	Jul. 06, 2020	Nov. 30, 2019	Apr. 30, 2013
Stockholders’ Equity (Details) [Line Items]
Authorized shares of preferred stock										5,000,000	5,000,000
Preferred stock, par value										$ 0.0001	$ 0.0001
Converted preferred stock	4,049		4,000
Convertible common stock	13,495,014		2,000,000			8,500,000
Redemption value			$ 400,000
Exchange agreements, description									the Company entered into Exchange Agreements with the holders of its Series B Preferred Stock, which shares of Series B Preferred Stock were originally issued in November 2019. Pursuant to the Exchange Agreements, the holders agreed to exchange their 115 shares of Series B Preferred Stock with a stated value of $115,000 and 575,000 warrants issued in connection with the Series B Preferred Stock for an aggregate of 1,437,500 shares of the Company’s common stock at a price of $0.08 per share. After the exchanges, there are no shares of the Company’s Series B Preferred Stock outstanding. The Company issued 1,437,500 shares of common stock which was more than the shares that would have been issued at the original conversion price of $0.20 per share or 575,000 shares of common stock, an excess of 862,500 shares of common stock. The excess shares were valued at a price of $0.08 per share. Consequently, in connection with this share exchange, the Company recorded a deemed dividend on this extinguishment of $69,000 during the year ended December 31, 2020. Accordingly, there are no shares of Series B Preferred Stock issued and outstanding as of December 31, 2021 and 2020.
Preferred stock conversion, description										The Series C Convertible Preferred Stock and the February Warrants each contain a beneficial ownership limitation that restricts each of the investor’s ability to exercise the February Warrants and convert the Series C Convertible Preferred Stock such that the number of shares of the Company common stock held by each of them and their affiliates after such conversion or exercise does not exceed 4.99% (or, at the election of the Investor, 9.99%) of the Company’s then issued and outstanding shares of common stock.
Warrants term										5 years
Exercise price										$ 0.3
Warrants period date										180 days
Subsequent financing, percentage										50.00%
Obligation percentage										1.00%
Placement agent warrants, description										pursuant to the terms of the offering, the Company issued Bradley Woods & Co, Ltd. and Katalyst Securities LLC warrants (the “Placement Agent Warrants”) to purchase up to an aggregate of 2,850,664 shares of common stock, or 10% of the shares of common stock issuable upon conversion of the Series C Preferred Stock and February Warrant Shares sold in the offering. The Placement Agent Warrants are exercisable for a period of five years from the closing date of the offering at an exercise price of $0.35 per share, subject to adjustment.
Risk free interest rate										0.50%
Expected dividend yield										0.00%
Expected term										5 years
Expected volatility										169.00%
Aggregate grant date fair value of placement agent warrants										$ 1,106,000
Shares of common stock										12
Proceeds from issuance of common stock											$ 2,115,733
Subscription receivable													$ 2,000
Total Subscription Receivable Value				$ 77,644
Common stock, par value										$ 0.0001	$ 0.0001
Investor invested amount										$ 100,000
Subsequent financing, percentage										50.00%
Liquidity damage, description										the Company is obligated to pay the investors liquidated damages in the amount of 1% of their subscription amount, per month, until such events are satisfied, subject to a cap of 6%.
Amortization of prepaid stock-based expense										$ 107,970	$ 578,924
Prepaid expenses and other current assets										0	107,970
Preferred stock value
Deemed dividend											69,000
Loss on debt extinguishment											(197,682)
Convertible long term notes payables					$ 330,000
Warrants issued					1,650,000
Aggregate number of common stock					4,125,000
Preferred stock stated value					$ 0.08
Stock-based compensation										$ 83,728
Purchase agreement, description		the Company entered into pursuant to securities purchase agreements with certain investors pursuant to which it sold warrants to purchase up to 14,253,323 shares of the Company’s common stock and 4,276 shares of the Company’s Series C Convertible Preferred Stock. The February Warrants are exercisable for a period of five years from the date of issuance at an exercise price of $0.30 per share, subject to adjustment. If, after a period of 180 days after the date of issuance of the February Warrants, a registration statement covering the resale of the February Warrant Shares is not effective, the holders may exercise the February Warrants by means of a cashless exercise. In addition, pursuant to the terms of the offering, the Company issued the Placement Agent Warrants to purchase up to an aggregate of 2,850,664 shares of common stock to its placement agents, or 10% of the shares of common stock issuable upon conversion of the Series C Preferred Stock and February Warrant Shares sold in the offering. The Placement Agent Warrants are exercisable for a period of five years from the closing date of the offering at an exercise price of $0.35 per share, subject to adjustment (see Series C Convertible Preferred Stock Financing above). Such warrants issued to various investors and to the placement agents were recorded as additional paid in capital with an offsetting debit applied against additional paid in capital, thus these warrants have no further accounting effect within the equity section.
Subscription Agreements [Member]
Stockholders’ Equity (Details) [Line Items]
Conversion price per share				$ 0.01
Shares of common stock				7,764,366
Proceeds from issuance of common stock				$ 75,644
Subscription receivable				$ 2,000
Securities Purchase Agreements [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock							29,993,750
Proceeds from issuance of common stock							$ 2,399,500
Common stock, par value							$ 0.08
Placement agent fees							$ 242,950
Other offering expenses							118,460
Total net proceeds							$ 2,038,090
Advisory Agreements [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock								5,117,343
Proceeds from issuance of common stock								$ 409,387
Common stock, par value								$ 0.08
Consulting Agreement [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock								3,468,841
Proceeds from issuance of common stock								$ 277,508
Common stock, par value								$ 0.08
Employment Agreement [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock								7,630,949
Proceeds from issuance of common stock								$ 610,476			610,476
Common stock, par value								$ 0.08
Exchange Agreements [Member]
Stockholders’ Equity (Details) [Line Items]
Convertible promissory notes, description					the Company entered into Exchange Agreements with the holders of certain convertible promissory notes. Pursuant to these Exchange Agreements, the holders agreed to exchange their convertible promissory notes of $330,000 and 1,650,000 warrants issued in connection with this debt for an aggregate of 4,125,000 shares of the Company’s common stock at a price of $0.08 per share
Loss on debt extinguishment											$ 198,000
Minimum [Member]
Stockholders’ Equity (Details) [Line Items]
Authorized number of shares												100,000,000
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Authorized number of shares												500,000,000
Warrant [Member]
Stockholders’ Equity (Details) [Line Items]
Warrants term						5 years
Exercise price						$ 0.2
Convertible promissory notes, description					The Company issued 4,125,000 shares of common stock which was more than the shares that would have been issued at the original conversion price of $0.20 per share or 1,650,000 shares of common stock, an excess of 2,475,000 shares of common stock. The excess shares were valued at a price of $0.08 per share.
Loss on debt extinguishment					$ 198,000
Purchase of warrants shares						250,000
Warrant, description										The warrants were valued on the grant date at approximately $0.33 per warrant for a total of $83,728 using a Black-Scholes option pricing model with the following assumptions: stock price of $0.35 per share (based on the quoted trading price on the date of grant), volatility of 169%, expected term of five year, and a risk-free interest rate of 0.46%.
Series A Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Authorized shares of preferred stock															1,000,000
Preferred stock, shares issued											4,000
Convertible into shares of common stock											2,000,000
Preferred stock value											$ 400,000
Series B Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Authorized shares of preferred stock										2,000	2,000			2,000
Preferred stock, par value										$ 0.0001	$ 0.0001
Preferred stock conversion, description					On April 15, 2020, the Company entered into Exchange Agreements with the holders of its Series B Preferred Stock whereby the holders agreed to exchange their 115 shares of Series B Preferred Stock with a stated value of $115,000 and 575,000 warrants issued in connection with the Series B Preferred Stock for an aggregate of 1,437,500 shares of the Company’s common stock at a price of $0.08 per share.
Preferred stock, shares issued
Preferred stock value
Aggregate number of common stock
Series C Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Authorized shares of preferred stock		4,280								4,280	4,280
Preferred stock, par value										$ 0.0001	$ 0.0001
Preferred stock, shares issued										227
Preferred stock value
Aggregate number of common stock
Series C Convertible Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Authorized shares of preferred stock		4,280								4,280
Preferred stock, par value										$ 0.0001
Convertible preferred stock stated value										1,000
Preferred stock outstanding, description										A holder of Series C Convertible Preferred Stock may not convert any portion of the Series C Convertible Preferred Stock to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99% (or, upon election by a holder prior to issuance, 9.99%) of the outstanding shares of the Company’s common stock after conversion, which beneficial ownership limitation may be increased by the holder up to, but not exceeding, 9.99%.
Preferred stock, shares outstanding										227
Series C Conversion Price [Member]
Stockholders’ Equity (Details) [Line Items]
Conversion price per share										$ 0.3
Series C Purchase Agreements [Member]
Stockholders’ Equity (Details) [Line Items]
Preferred stock conversion, description		the Company entered into securities purchase agreements (collectively, the “Series C Purchase Agreements”) with certain institutional and accredited investors for the sale of an aggregate of 4,276 shares of the Company’s Series C Convertible Preferred Stock and warrants (the “February Warrants”) to purchase up to 14,253,323 shares (the “February Warrant Shares”) of the Company’s common stock for gross proceeds of approximately $4,276,000, before deducting placement agent and other offering expenses of $481,898 which are offset against the proceeds in additional paid in capital. The offering closed on February 12, 2021. Accordingly, the Company recognized a total deemed dividend of $1,403,997 for the beneficial conversion feature in connection with the issuance of these Series C Convertible Preferred Stock.